Pharma faces $2 billion cut in drugs bill as Greece debt crisis deepens
This article was originally published in Scrip
Pharmaceutical companies are likely to be reeling today with the announcement that €2.1 billion ($2.8 billion) of healthcare spending cuts will take place during 2011–15 in Greece. These cuts will be implemented through widening the use of electronic prescribing, and drug price cuts. This will not only negatively impact pharmaceutical company sales in Greece, but also sales in other countries which reference Greek drug prices.